Blueprint Medicines Corp
BPMC
Market Cap$6.55B
Close$
$95.39
10.9% downside
Current Fair Value
10.9% downsideOvervalued by 10.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.55 Billion |
|---|---|
| Enterprise Value | $6.08 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-8.37 |
| Beta | 1.24 |
| Outstanding Shares | 61,200,000 |
| Avg 30 Day Volume | 698,812 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -12.92 |
|---|---|
| PEG | 42.93 |
| Price to Sales | 26.75 |
| Price to Book Ratio | 53.5 |
| Enterprise Value to Revenue | 24.37 |
| Enterprise Value to EBIT | -12.61 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 1.83 |
Revenue Sources
No data
ESG Score
No data
About Blueprint Medicines Corp
CEO: Jeffrey Albers